QuickView for PDE10A;jsessionid=8F605E84A4D2653566F7019E6E54FE1C;jsessionid=0A0E7AABB9E9D27F701B7EF6A14A3BFF;jsessionid=20E1ABBF16F34C3CEDCE021E739BD94D;jsessionid=96CD151C549BB9F09D828ADFB522FE52;jsessionid=CFFF0FF06AAFF6173D02287D60EE7811 (gene)

1. Inhibition of CXCR2 enhances CNS remyelination via modulating PDE10A/cAMP signaling pathway.
2. Design, synthesis, and behavioral evaluation of dual-acting compounds as phosphodiesterase type 10A …
3. PARACENTRAL ACUTE MIDDLE MACULOPATHY ASSOCIATED WITH PHOSPHODIESTERASE-5 INHIBITOR THERAPY.
4. Effects of phosphodiesterase 5 inhibition on cardiovascular function in resistant hypertension: A sy…
5. Role of PDE10A in vascular smooth muscle cell hyperplasia and pathological vascular remodelling.

There were no clinical trials for PDE10A;jsessionid=8F605E84A4D2653566F7019E6E54FE1C;jsessionid=0A0E7AABB9E9D27F701B7EF6A14A3BFF;jsessionid=20E1ABBF16F34C3CEDCE021E739BD94D;jsessionid=96CD151C549BB9F09D828ADFB522FE52;jsessionid=CFFF0FF06AAFF6173D02287D60EE7811